References
- Lamden K, Watson JM, Knerer G, Ryan MJ, Jenkins PA. Opportunist mycobacteria in England and Wales: 1982 to 1994. Commun Dis Rep CDR Rev 1996;6:R147–51.
- McGarvey J, Bermudez LE. Pathogenesis of mycobacterial infections. Clin Chest Med 2002;23:569–83.
- Grange JM, Yates MD. Infections caused by opportunist mycobacteria: a review. J R Soc Med 1986;79:226–9.
- Field SK, Cowie RL. Lung disease due to more common non-tuberculous mycobacteria. Chest 2006;129:1653–72.
- Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax 2000;55:210–8.
- ATS Mycobacterial Diseases Subcommittee. An official ATS/IDSA statement: diagnosis, treatment, and prevention of non-tuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367–416.
- Standards Unit, Evaluations and Standards Laboratory. National Standard Method: Investigation of specimens for Mycobacterium species. London: Health Protection Agency; 2006. Available from: http://www.hpa.org.uk/webc/HPAwebfile/HPAweb_C/1317132693180 (accessed 12 August 2009).
- Brown-Elliott BA, Griffith DE, Wallace RJ. Diagnosis of non-tuberculous mycobacterial infections. Clin Lab Med 2002; 22:911–25.
- Somoskovi A, Mester J, Hale YM, Parsons LM, Salfinger M. Laboratory diagnosis of nontuberculous mycobacteria. Clin Lab Med 2002;23:585–97.
- Dailloux M, Abalain ML, Laurain C, Lebrun L, Loos-Ayav C, Lozniewski A, . Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J 2006;28:1211–5.
- Andréjak C, Lescure FX, Pukenyte E, Douadi Y, Yazdanpanah Y, Laurans G, . Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France. Thorax 2009;64:291–6.
- Santin M, Dorca J, Alcaide F, Gonzalez L, Casas S, Lopez M, Guerra MR. Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease. Eur Respir J 2009;33:148–52.
- Tanaka E, Amitani R, Niimi A, Suzuki K, Murayama T, Kuze F. Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1997;155: 2041–6.
- Jeong YJ, Lee KS, Koh WJ, Han J, Kim TS, Kwon OJ. Nontuberculous mycobacterial pulmonary infection in immunocompetent patients: comparison of thin-section CT and histopathologic findings. Radiology 2004;231:880–6.
- Research Committee, British Thoracic Society. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Thorax 1994;49:442–5.
- Sauret J, Hernández-Flix S, Castro E, Hernández L, Ausina V, Coll P. Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months’ chemotherapy. Tuber Lung Dis 1995;76:104–8.
- Griffith DE, Brown-Elliott BA, Wallace RJ. Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study. Clin Infect Dis 2003;37:1178–82.
- Shitrit D, Baum GL, Priess R, Lavy A, Shitrit AB, Raz M, . Pulmonary Mycobacterium kansasii infection in Israel, 1999–2004. Chest 2006;129:771–6.
- The Research Committee of the British Thoracic Society. Pulmonary disease caused by M. malmoense in HIV negative patients: 5-year follow-up of patients receiving standardized treatment. Eur Respir J 2003;21:478–82.